Rohan Palekar

In this episode, Rohan Palekar, CEO of 89bio, discusses the challenges in the NASH therapeutics market, the importance of safety and convenience in patient recruitment, and the impact of good data on investment. The chapter also highlights how 89 Bio efficiently advanced their mission through strategic thinking, creative trial designs, and fiscal stewardship. The challenges of integrating people within a company and optimizing antibody development are also explored.